References

Halting angiogenesis suppresses carcinoma cell invasion

10.1038/nm1197-1222 · 1997 · External reference

Invasion and metastasis

10.1007/bf00049488 · 1996 · External reference

Matrix metal loproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis

1998 · External reference

Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors

10.1016/s0002-9440(10)65550-2 · 1998 · External reference

Stromal reaction in cancer tissue: Pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions

10.1111/j.1440-1827.1998.tb03820.x · 1998 · External reference

Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer

1993 · External reference

Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions

1997 · External reference

Stromal fibroblasts are required for PC-3 human prostate cancer cells to produce capillary-like formation of endothelial cells in a three-dimensional co-culture system

1997 · External reference

Regulation of angiogenesis by scatter factor

1997 · External reference

Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer

1996 · External reference

92 kDa type IV coll agenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer

10.1002/(sici)1097-0215(19960103)65:1<57::aid-ijc10>3.0.co;2-f · 1996 · External reference

Metastatic colorectal cancer cells induce matrix metal loproteinase release by human monocytes

10.1007/bf00157680 · 1996 · External reference

Contributions of tumor and stromal matrix metal loproteinases to tumor progression, invasion and metastasis

10.1007/bf00690603 · 1995 · External reference

Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases

1996 · External reference

Induction of membrane-type matrix metal loproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells

10.1023/a:1018404927753 · 1997 · External reference

Isolation from patients with breast cancer of antibodies specific for antigens associated with breast cancer and other malignant diseases

10.1073/pnas.73.6.2101 · 1976 · External reference

Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes

10.1007/bf01533513 · 1994 · External reference

Oncogenic proteins as tumor antigens

10.1016/s0952-7915(96)80079-3 · 1996 · External reference

Lysis of human normal and sarcoma cells in tissue culture by normal human serum: implications for experiments in human tumor immunology

10.1093/jnci/58.5.1233 · 1977 · External reference

Inhibition of effector cell function in human antibody-dependent cellular cytotoxicity by sera from cancer patients

10.1093/jnci/58.5.1485 · 1977 · External reference

Ex vivo removal of serum IgG in a patient with colon carcinoma: Some biochemical, immunological and histological observations

10.1002/1097-0142(197807)42:1<1::aid-cncr2820420102>3.0.co;2-n · 1978 · External reference

B lymphocytes secreting IgG linked to latent transforming growth factor-(beta) prevent primary cytolytic T lymphocyte responses

10.1093/intimm/10.3.355 · 1998 · External reference

Suggestive evidence that the “blocking antibodies” of tumor-bearing individuals may be antigen-antibody complexes

10.1073/pnas.68.6.1372 · 1971 · External reference

Immunological enhancement: a study of blocking antibodies

10.1016/s0065-2776(08)60685-9 · 1972 · External reference

B cells inhibit induction of T cell-dependent tumor immunity

10.1038/nm0598-627 · 1998 · External reference

B cell-mediated downregulation of IFN-gamma and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state

10.1093/intimm/10.8.1057 · 1998 · External reference

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

10.1038/350423a0 · 1991 · External reference

Selective implantation and growth in rats and mice of experimental liver metastasis in acinar zone one

1989 · External reference

Anti-tumor immunity in B lymphocytedeprived mice: I

1978 · External reference

Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: apolar localization corresponds to malignant transformation

10.1007/s004280050083 · 1997 · External reference

The prognostic significance of sialyl-Tn antigen in women with breast carcinoma treated with adjuvant chemotherapy

10.1002/(sici)1097-0142(19971215)80:12<2240::aid-cncr4>3.0.co;2-y · 1997 · External reference

The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis

10.1006/excr.1998.4066 · 1998 · External reference

Stimulatory effects of immune reaction upon growths of untransplanted tumors

1994 · External reference

Antibody and complement modulation of tumor cell growth in vitro and in vivo

1978 · External reference

Macrophage activation and immunomodulation by myeloperoxidase

10.3181/00379727-199-43348 · 1992 · External reference

Effect of interleukin-1 -beta on metastasis formation indifferent tumor systems

10.1093/jnci/83.2.119 · 1991 · External reference

Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary

10.1002/(sici)1096-9896(199708)182:4<385::aid-path861>3.0.co;2-q · 1997 · External reference

Delayed mammary tumor progression in Muc-1 null mice

10.1074/jbc.270.50.30093 · 1995 · External reference

Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents

10.1093/jnci/90.21.1648 · 1998 · External reference

First results for resetting the anti-tumor immune response by immune corrective surgery in colon cancer

10.1016/s0002-9610(98)00192-5 · 1998 · External reference

Inhibition of tumor growth by elimination of granulocytes

10.1084/jem.181.1.435 · 1995 · External reference

Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

10.1084/jem.175.1.139 · 1992 · External reference